This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignees: Hamamatsu University School of Medicine, Kowa Company Limited. Active years: 2021.
Company Filing History:
1 out of 43 
1 out of 603 
Years Active: 2021
Title: Noboru Kaneta: Innovator in Pharmaceutical Composition
Introduction
Noboru Kaneta is a distinguished inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of aortic aneurysms. His innovative approach addresses critical medical challenges and showcases his expertise in developing therapeutic agents.
Latest Patents
Noboru Kaneta holds a patent for a pharmaceutical composition aimed at treating abdominal aortic aneurysms. The patent, which is a significant advancement in pharmacotherapy, provides a therapeutic agent comprising (−)-6-[3-[3-cyclopropyl-3-[(1R,2R)-2-hydroxycyclohexyl]ureido]propoxy]-2(1H)-quinolinone or a salt thereof, or a solvate of these. This invention represents a promising solution for patients suffering from this serious condition.
Career Highlights
Throughout his career, Noboru Kaneta has worked with notable institutions, including Hamamatsu University School of Medicine and Kowa Company Limited. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Noboru Kaneta has collaborated with esteemed colleagues such as Naoki Unno and Hiroki Tanaka. These partnerships have fostered an environment of innovation and have led to advancements in pharmaceutical research.
Conclusion
Noboru Kaneta's contributions to the field of pharmaceuticals, particularly in the treatment of aortic aneurysms, highlight his role as a key innovator. His patent and collaborations reflect his commitment to advancing medical science and improving patient outcomes.